Discussion of Perspectives on Various Innovative Statistical Methodologies for Alzheimer’s Disease Clinical Trials
Advances in our understanding of AD disease progression and treatment effects provide a opportunity to explore some innovative statistical methodologies. Rigorous evaluation and open dialogue are essential to utilize these methods effectively, ensuring they enhance trial efficiency and maintain the rigor required for regulatory decision-making.
Authors
- John Lawrence (ORCID: https://orcid.org/0000-0002-9892-2753)
Institutions
- United States Food and Drug Administration (US)
Publication Details
- Journal
- Alzheimer s & Dementia
- Published
- 2025-12-01
- DOI
- https://doi.org/10.1002/alz70859_110767
- Primary Topic
- Dementia and Cognitive Impairment Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00